RELEASE DATE | DECEMBER 2012

1 CONTINUED

For all faculty, physicians, students and staff of Temple’s healthcare enterprise.

TUH First in World to Offer New Cryotherapy System for Patients“I was ready to rip the cancer out myself if I had to,” said Sebastian “Sonny” Galati.

That was how eager he was to have the cancer in his esophagus removed. Michael S. Smith, MD, MBA, Medical Director of Temple’s Esophageal Program, diagnosed Galati with Barrett’s esophagus and told him it had progressed to the point that he had early cancer of the esophagus.

“My whole world stopped when I heard that,” said Carla Galati, Sonny’s wife of 42 years, and Assistant Hospital Director of Human Resources at Temple’s Episcopal Campus.

Dr. Smith caught the cancer early and told Mr. Galati about his treatment options, including surgery, radiation, and chemotherapy. Galati ultimately opted for the new truFreeze® Spray Cryotherapy System. In November, Temple University Hospital became the first in the world to offer it to patients with esophageal disease, including Barrett’s esophagus and esophageal cancer. Galati was one of the first patients to get the treatment.

The minimally invasive technology involves placing a small catheter in an endoscope to spray extremely cold liquid nitrogen (-196°C) to eradicate targeted tissue inside the esophagus. The rapid freeze and slow thaw of tissue has

been proven to destroy the targeted cells without disturbing the underlying connective tissue, providing a framework for healthy cells to regenerate.

Spray cryotherapy is an outpatient procedure that typically permits patients to quickly resume normal activity. “Our first truFreeze® patients have all reported easy recoveries with minimal discomfort,” said Dr. Smith.

Patients then come back for follow-up endoscopies and additional treatments to make sure all of the diseased tissue is destroyed.

“Offering our patients spray cryotherapy in addition to other endoscopic treatments makes Temple a truly comprehensive center for the management of Barrett’s esophagus and esophageal cancer,”

Dr. Smith added. “Having truFreeze® at Temple keeps us on the cutting edge of the treatment of these conditions.”

Sonny Galati says he feels great, that the treatment was easy and painless, and that he’s thankful he had spray cryotherapy as a treatment option. “I’m blessed to be able to have this taken care of, and to have Dr. Smith,” added Galati. “I can’t say enough about him.”

An endoscope directs the spray of extremely cold liquid nitrogen to vaporize targeted tissue inside the esophagus.

Dr. Smith examines Sonny Galati.

Transformation is a Team Effort! During a special awards ceremony four weeks ago, I was honored as a “CEO of the Year” by the Philadelphia Business Journal. (See story, page 8.)

Such public recognition of professional accomplishments is rewarding on multiple levels, not the least of which is that it reflects positively on each and every one of you – my many Temple colleagues who have contributed so vitally and consistently to the successful transformation of our healthcare enterprise.

In little more than 18 months, we have moved outside of the shadow of other local providers to assume a position as a major force among regional and national academic health centers. Our emergence as a pioneer and leader in several key areas — including robotic surgery, cardiovascular disease, cancer treatment and research, community-based population-health programs, to name a few — is a testament to the commitment you have made to our shared vision of Temple Health.

As we near the close of 2012, we can all look back on the year with a sense of pride. We have made much progress together, but our job is not complete. With your continued support and dedication, I am confident that we will achieve a further transformation of our healthcare enterprise in 2013.

Please accept my sincerest appreciation for the strong support you have shown the leadership team, our patients and your co-workers. Best wishes to you and your family for a very happy and safe holiday season.

Larry R. Kaiser, MD, FACS Senior Executive Vice President for Health Sciences, Temple University Dean, Temple University School of Medicine President & CEO, Temple University Health System

2 CONTINUED

What’s in a Name?Temple’s newly-named Section of Nuclear Medicine and Molecular Imaging

When Alan Maurer, MD, Professor of Radiology and Medicine at Temple University School of Medicine and director of Nuclear Medicine and Molecular Imaging, was president of the national Society of Nuclear Medicine in 2001, he was one of the most vocal supporters of a move to change the society’s name to include “Molecular Medicine.” A decade later, in 2011, he was still at it, explaining the rationale in an editorial in the Journal of Nuclear Medicine, citing the field’s rapid and inevitable growth to include a dazzling array of molecular techniques, and its challenges.

“We didn’t want to give up all of our roots, but we wanted to recognize the growth and expansion of the field,” he said. “The spectrum of nuclear medicine’s molecular techniques continues to grow, and we’re seeing the development of more targeted treatments.”

Nuclear medicine has undergone an evolution in the last few decades. While it originally was

Dr. Maurer (left) and colleagues in TUH’s Section of Nuclear Medicine and Molecular Imaging.

focused on showing changes in the physiology and chemistry of the body, the field now uses a wide range of imaging technologies, including CT and MRI fusion of anatomic images, to better localize and measure biological processes at

the cellular and molecular levels. Specialists may develop radioactive labels to follow red and white blood cells throughout the body, for example, or use radiolabeled antibodies for tumor detection, or as guided missiles to deliver anti-tumor drugs. Others may image dopamine receptors in the brain to better understand and detect Parkinson’s

disease, or study amyloid plaques in the brain implicated in Alzheimer’s disease.

“While the name has changed in our section to ‘Nuclear Medicine and Molecular Imaging,’ nearly everyone still knows it as Nuclear Medicine,” said Dr. Maurer. “We’re trying to be on the leading edge of where the field is going. We’re hoping that our patients begin to understand that we really do a wide variety of things to help them.”

“The spectrum of nuclear medicine’s molecular techniques continues to grow, and we’re seeing the development of more targeted treatments.”

Research Breakthrough:

Temple Researchers Identify Gatekeeper Protein That May Help Prevent DiseaseResearchers at Temple University’s Center for Translational Medicine and the University of Pennsylvania School of Medicine have identified a protein, MICU1, that serves as a gatekeeper for controlling the rush of calcium into the cell’s powerhouse, the mitochondria. Without this calcium spigot under control, levels can run amok, contributing to cardiovascular disease, diabetes and neurodegeneration.

The findings, reported online in the journal Cell, may help scientists better understand and target certain cellular processes gone awry, leading to new therapies for disease.

“Calcium is crucial for cell signaling, and keeping calcium at a certain level in the mitochondria is important to help regulate various cell processes and physiology,” said co-senior author Muniswamy Madesh, PhD, Assistant Professor of Biochemistry.

“We’ve shown this gatekeeper establishes a threshold for calcium and prevents it from rushing in and overwhelming the mitochondria, which if unregulated, can act as a sponge and soak up large amounts of calcium in the cell,” he added. “These results may help us find new ways to control calcium levels and head off problems that might lead to disease.”

Muniswamy Madesh, PhD

3 CONTINUED

Robotic ENT Surgery Now Performed at TUH Surgeons at Temple University Hospital continue to expand and enhance the versatility of the hospital’s robotic surgery capabilities in cardiac surgery, gynecology, urology, and – most recently – Otolaryngology-Head and Neck Surgery, also known as ENT (ear, nose and throat).

Jeffrey Liu, MD, Director of TUH’s Division of Head and Neck Oncologic Surgery, performed the hospital’s first robotic ENT surgeries in mid-October, using one of the hospital’s three da Vinci® Surgical Systems.

For patients who have cancer in hard-to-see and hard-to-reach areas deep in the mouth and throat, the traditional surgical approach may require disfiguring incisions through the lip and the jaw to gain access to the tumor.

Using an approach called TransOral Robotic Surgery (TORS), Dr. Liu is able to reach the tumors through the patient’s mouth and remove the cancer with an extreme level of flexibility that only the surgical robot provides.

“The robot’s camera provides superior visualization and magnification to allow precise

Jeffrey Liu, MD, prepares for surgery.

identification of tumor edges, blood vessels and nerves. Using the robot’s tiny, flexible arms, I can work around corners deep in the patient’s mouth with great precision,” he adds.

The incision-less TORS approach also spares patients from visible scarring and disfigurement and protects facial and neck tissue and muscle which can affect the patient’s ability to swallow, taste, breathe, speak, smell, and hear.

Treatments for head and neck cancer include surgery, radiation therapy, and chemotherapy – which are employed alone or in combination. In appropriate cases, robotic ENT surgery could be a first-line approach to treatment. “More patients may be able to be treated surgically because we can now remove more lesions that historically would be difficult to see or reach,” says Liu. “We now have an additional treatment modality that was not previously available for many patients.”

“Selecting the right patient and the right cancer for surgery is the key to successful application of the da Vinci robot for mouth and throat cancers,” emphasizes Liu.

Team Temple Makes Strong Showing at Heart Walk!How would you describe an amazing show of support for the fight against heart disease?

You might say that it looks like the 709 total walkers fielded by Temple Health during the 2012 Philadelphia Heart Walk, held in South Philadelphia on November 4.

Members of the Temple contingent – easily identified at the event, thanks to red “Team Temple” shirts – hailed from across the healthcare enterprise. They signed up family members, friends, and colleagues and brought them to the walk.

Thanks to this enthusiasm, Temple Health raised more than $27,000 for the American Heart Association and the larger fight against heart disease and stroke. This figure was in addition to Temple’s $15,000 event sponsorship.

4 CONTINUED

Nearly four decades since the Vietnam War, the conflict continues to be felt among that nation’s poorer populations, with more than 100,000 Vietnamese having suffered amputations due to land mines, as well as through infections, diabetic complications and other illnesses.

That’s why five members of Temple’s School of Pharmacy traveled recently to the nation’s southern region to bring a pharmacy component to an existing medical mission. Clinical Professor of Pharmacy Practice Charles Ruchalski, PharmD, who served as the faculty sponsor for the trip, and students Thao Nguyen, Montano Recinto, Chi Tran and Hang Nguyen teamed up with faculty and students from Mercer University School of Engineering in Macon, Georgia, for the month-long medical mission.

The team visited local medical clinics and hospitals, as well as nursing homes, orphanages and Di Linh leprosy colony in Saigon, Can Tho, Dong Thap and Vung Tau. They treated more than 1,500 patients, assisting in the fitting of over 200 prostheses on amputees. They also donated more than 450 gift packages containing 5 kg of rice, noodles and other supplies.

“We did traditional pharmacy dispensing activities and patient counseling, but we also conducted more advanced clinical activities, such as checking vital signs, injecting medications, assisting with translation and, most uniquely, assisting with the fitting of prosthetics,” said Ruchalski.

Ruchalski said that working 13 hours a day in 105-degree temperatures provided the pharmacy students with a unique opportunity to gain non-traditional experience.

“Sometimes, what the students traditionally think of as pharmacy is a temperature-controlled environment in the United States where you are dispensing medication, counseling patients or performing clinical pharmacy activities,” he said. “This had some of that, but it also had lugging kilos of rice, sawing a metal prosthetic or pulling on a patient’s legs so a doctor can manipulate their spine.”

Ruchalski said he hopes to continue to offer the trip annually as “an altruistic opportunity” for Temple pharmacy students.

Charles Ruchalski, PharmD, administers injectable medication to a patient at a clinic in Vietnam.

Pharmacy School Extends its Global Outreach to Vietnam

Ribbon-Cutting Ceremony Marks Major Investments in Endoscopy and Pharmacy at NortheasternPhysicians and staff gathered at Northeastern Campus on October 21 for a ribbon-cutting ceremony marking $1.4 million in upgrades to the Endoscopy Suite and Pharmacy.

Additions to Endoscopy include two new patient bays, a new waiting room, and an improved instrument-cleaning and processing area. Patient amenities, such as new chairs, flooring, furniture, and TVs were also installed during the project. In Pharmacy, workers installed new regulatory-compliant positive and negative pressure rooms for the preparation of chemotherapy agents.

On hand for the ribbon-cutting ceremony were John Kastanis, President and CEO of Temple University Hospital (TUH), and Kathleen Barron, Executive Director of Episcopal and Northeastern campuses.

“Investing in the high-quality ambulatory care available at Northeastern is part of the larger, positive trend of change at Temple Health,” said Kastanis, as he spoke to the assembled guests.

Ribbon-cutting ceremony for Northeastern’s upgraded Endoscopy Suite and Pharmacy space.

During her remarks, Barron noted the project’s dual-focus: accommodating growth in patient volume and meeting regulatory requirements for free-standing Ambulatory Surgery Centers and Pharmacy space used for the preparation of chemotherapy agents.

Temple’s William Maul Measey Institute for Clinical Simulation and Patient Safety has earned reaccreditation as a Level I Education Institute by the American College of Surgeons (ACS). Accreditation lasts for three years and represents the highest level of quality and standards for surgical education.

The Institute, which was one of the first such programs to receive ACS accreditation in 2006, provides a vital teaching and training function for medical students, residents, physicians, nurses and other health professionals. Programmable and anatomically detailed mannequins help teach a range of clinical and decision-making skills, while other modules and technologies allow participants to practice surgical skills, from suturing to laparoscopy. In many cases, standardized patients – many of whom have acting experience – are trained to simulate real-life medical situations, enabling learners to practice a variety of all-important patient care and communications skills.

“There’s been an explosion of interest in the medical simulation field, and these programs are becoming increasingly common in medical schools today and are applicable for nearly all medical training curricula,” said Professional and Technical Director Jane Cripe, who has been at the Institute since its inception in 2005. “A real strength of our program is a fully developed medical student training simulation module that includes all four years of medical school.”

Cripe points to a noticeable improvement in technology since 2005 – simulators were tethered to walls, for example, and hardly as mobile as they are today, and many programs are taking advantage of advances in robotics and virtual reality.

“We’re extremely excited to see a continually growing need and demand for the Institute’s resources,” she said.

5 CONTINUED

Temple Simulation Institute Earns Reaccreditation

Temple Opens First Podiatric-Run Lymphedema and Diabetic Ulcer ClinicThe Temple University School of Podiatric Medicine (TUSPM), in collaboration with corporate partner Devon Medical Products, recently opened the city’s first podiatric-run Lymphedema and Diabetic Ulcer Clinic at the Temple Foot and Ankle Institute, located on 8th Street, between Cherry and Race Streets.

Lymphedema is swelling from fluid retention that is caused by blockage of the lymph vessels. Diabetic ulcers are wounds or open sores that will not heal or keep returning. Both conditions present a potentially serious risk of infection.

The goal of new clinic is to prevent foot amputation by treating patients’ symptoms early and quickly.

A fully-equipped “hospital room” and “patient” in Temple’s Simulation Lab creates a high-tech learning environment in which second-year medical students learn to assess patient safety.

6 CONTINUED

Dramatic Liver Transplant Saves Young Mother’s LifeEverything was perfectly normal.

That’s how Antonio Lagronio describes his wife’s second pregnancy. But at 32 weeks, Sheila Lagronio began having abdominal pain and her eyes took on a yellow tint. A trip to the hospital was uneventful until the results of her blood tests came back and then “all of the nurses started running,” says Antonio.

Sheila was going into liver failure due to HELLP syndrome – a rare but life-threatening obstetric complication that can come on fast. HELLP is an abbreviation of the three main features of the syndrome: Hemolysis, Elevated Liver enzymes, and Low Platelet count.

For the safety of the baby and Sheila, doctors recommended an immediate C-section. The baby girl was born healthy and doctors hoped Sheila’s liver function would improve. Instead, it got worse. She was soon put on a ventilator and fell into a coma. At this point, a liver transplant was her only hope.

That’s when Sheila was transferred to Temple.

“Patients like Sheila are critically ill and can die at any moment,” says Ashokkumar Jain, MD, FACS, Director of the Liver Transplantation Program at Temple. “She required a transplant as quickly as possible.”

Sheila and Antonio Lagronio and their two children.

According to Dr. Jain, the Temple Liver Transplantation Program takes an aggressive, team approach to care. Patients are accepted around the clock and are quickly evaluated and listed for transplant. The program has grown into the third largest in the Gift of Life’s region (which consists of seven liver transplant centers) and enjoys excellent survival rates and patient satisfaction scores.

“We are used to taking on complex cases,” says Dr. Jain, who has personally performed more than 1,000 liver transplants during his career. “Sheila was one of two patients with HELLP and a similar condition on whom we have done liver transplants in recent years at Temple.”

Just two days after being transferred to Temple, Sheila received a new liver. She made a rapid recovery and was soon able to return home where she was reunited with her son and new baby girl. Today, she is doing fine and her long-term prognosis is very good.

Her husband – who at the time of the transplant was running between his two-year-old son at home, his new baby in the hospital and his critically ill wife at Temple – distinctly remembers the date Sheila received the gift of life.

“It was May 8…Mother’s Day,” he says.

Successful Surveys at Temple!Temple University Hospital and its affiliate campuses of TUH-Episcopal and TUH-Northeastern, as well as Fox Chase Cancer Center, successfully completed full-accreditation surveys by The Joint Commission.

Temple University HospitalA team of six surveyors conducted an in-depth review of TUH’s entire patient-care process, including interviews with patients and staff, and close scrutiny of documents, facilities, and equipment. The team’s lead surveyor praised TUH’s staff and physicians for their consistently high level of compassion and competence – and TUH expects to remain fully accredited for three additional years.

TUH’s LVRS ProgramIn a separate survey, a different team of surveyors from The Joint Commission conducted a two-day review of TUH’s Lung Volume Reduction Surgery program – which successfully earned recertification for another two years. In fact, the lead surveyor dubbed TUH’s program “the flagship Lung Volume program in the country.”

Fox Chase Fox Chase Cancer Center also successfully completed a full accreditation survey of the American Oncologic Hospital by The Joint Commission. After a team of three surveyors conducted in-depth reviews of Fox Chase’s entire patient care process, clinical environment, documents, facilities and equipment, they expressed admiration to the campus’ clinical executives and quality leaders for the dedication and compassion of Fox Chase’s staff and physicians, while praising Fox Chase as a “high-functioning organization.” As a result of the survey, Fox Chase expects to remain fully accredited for the next three years.

7 CONTINUED

Fox Chase Leader Tours China with Mayor Nutter

Temple Hosts Regional Pharmacy Residency ShowcaseTemple University Hospital’s Department of Pharmacy recently hosted the Delaware Valley Society of Health-System Pharmacists (DVSHP) Regional Residency Showcase, in the Temple Health Sciences Student Faculty Center. The event featured representatives from Temple and 30 other pharmacy residency programs throughout the region, who presented information about their programs to hundreds of prospective students.

“Hosting this event helps Temple stand out to students as they assess potential Pharmacy programs and choose the one that is right for them,” according to TUH’s Director of Pharmacy Services Frank Dahl, R.Ph., M.S.

The showcase also featured a panel discussion in which Dahl, along with Residency Program Directors and residents, described the Pharmacy School application process and offered tips for successful interviewing.

Temple Pharmacy Residents spread the word about what Temple has to offer to prospective students at Regional Residency Showcase, hosted by Temple.

Fox Chase Cancer Center will be sharing its oncologic expertise with peers at Tianjin Medical University Cancer Institute and Hospital in Tianjin, China, thanks to an agreement signed in the Chinese port city on December 3.

Kurt Schwinghammer, PhD, Vice President of Research & Development Alliances at Fox Chase and head of Fox Chase International, was a member of a contingent of Philadelphia leaders in medicine, education, law, and the arts traveling with Mayor Michael Nutter to Tianjin — which, since 1980, has been a Sister City of Philadelphia.

Mayor Nutter’s trip focused on encouraging international investment in Philadelphia and strengthening relationships between important local institutions and their counterparts in China. The trip also took the group about 70 miles northwest of Tianjin to Beijing, where Nutter, current president of the U.S. Conference of Mayors, spoke on urban sustainability.

According to Schwinghammer, urban sustainability - the concept central to the Mayor’s activities in China - is linked to Fox Chase’s mission. “Cancer is now the leading cause of death in China, with lung cancer being at the top of the list. It is likely that there is a relationship between long-term exposure to air pollution and cancer,” he explained.

The partnership forged in Tianjin is not the first of its kind for Fox Chase. Through Fox Chase International, the Center seeks to align the skills and resources of cancer research, diagnosis and treatment available at Fox Chase with the extraordinary growth of cancer treatment and diagnostic requirements in China and other nations. So far, Fox Chase has formed relationships with institutions in six cities in China and India.

Kurt Schwinghammer (right) and Philadelphia Mayor Nutter in China.

RECOGNITIONS

8 CONTINUED

Larry Kaiser, MD, FACS, Named a “CEO of the Year”by The Philadelphia Business Journal

Dr. Kaiser recevies his award from Sue Schick, CEO, UnitedHealthcare of Pennsylvania and Delaware.

Larry Kaiser, MD, FACS, President and CEO of Temple University Health System, has been named a “CEO of the Year” at the 2012 Healthcare Innovation Awards, sponsored by The Philadelphia Business Journal.

Dr. Kaiser was among three area healthcare CEOs who accepted their awards at a breakfast ceremony on November 8, at the Sheraton Hotel in Philadelphia.

“I am honored to accept this distinguished leadership award – which is truly a testament to the unwavering commitment and collective efforts of the physicians and staff of the Temple University Health System who continue to work together to transform our enterprise into one of the region’s premier academic medical centers,” said Dr. Kaiser, who is also Dean of Temple University School of Medicine and Senior Executive Vice President of Health Sciences for Temple University.

Raul A. DeLa Cadena, MD Enrique Hernandez, MD Anita Colon

Three Temple Health professionals have been selected as among “Delaware Valley’s Most Influential Latinos” for 2012.

Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine; Enrique Hernandez, MD, Chair of Obstetrics, Gynecology and Reproductive Sciences at Temple University School of Medicine; and Anita Colon, Director of Patient Financial Services for Temple University Health System, were selected for the honor by the Delaware Valley’s Most Influential Latinos Foundation.

They Foundation’s stated mission is to support and encourage Latino leadership and empowerment by recognizing individuals who have made significant contributions to the Delaware Valley’s Latino community and the community at large.

Dr. DeLa Cadena, Dr. Hernandez, and Ms. Colon were recognized, along with the other honorees, at a Gala Dinner and celebration at the Hyatt Regency Philadelphia at Penn’s Landing on November 29.

Temple Health Professionals:

Named Among the Region’s Most Influential Latinos

RECOGNITIONS

John Daly, MD, Harry C. Donahoo Professor of Surgery, Surgical Director of the Measey Institute for Clinical Simulation and Patient Safety, and Dean Emeritus of the Temple University School of Medicine, was named Vice President of the ACS, and will work with other ACS officers and the Board of Regents to improve the continuing education of surgeons, thereby enhancing the quality of surgical care for all patients.

Enrique Hernandez, MD, Abraham Roth Professor and Chair of Obstetrics, Gynecology and Reproductive Sciences at Temple University School of Medicine, was elected to the ACS’ 22-member Board of Regents, which is responsible for governing the College.

Amy Goldberg, MD, Professor of Surgery and Director of the Surgical Residency Program at Temple University School of Medicine, and Section Chief of Trauma and Surgical Critical Care at Temple University Hospital, was named to the ACS’ Board of Governors, which serves as the official communications link between ACS Fellows in different regions of the country and the ACS Board of Regents.

9 CONTINUED

Temple Medical Faculty Well Represented in Leadership Ranks of ACSThree Temple University School of Medicine faculty members have recently been appointed to leadership positions in the American College of Surgeons (ACS) – the largest organization of surgeons in the world, and the nation’s premier standards-setting body for surgical practice and education.

Bennett Lorber, MD, MACP

Bennett Lorber, MD, MACP, Thomas M. Durant Professor of Medicine at Temple University School of Medicine and Professor of Microbiology and Immunology, Section of Infectious Diseases, has been selected by the American College of Physicians Board of Regents to receive the Jane F. Desforges Distinguished Teacher Award.

This national award, given to a single person annually, is bestowed upon a Fellow or Master of the College who “has demonstrated the ennobling qualities of a great teacher as judged by the acclaim and accomplishments of former students who have been inspired and have

achieved positions of leadership in the field of medical education, primarily as teachers.” Dr. Lorber will receive the prestigious teaching award at the ACP’s Internal Medicine 2013 meeting, to be held in San Francisco next April.

Dr. Lorber, an internationally-renowned infectious disease specialist, is past president of The College of Physicians of Philadelphia and the Anaerobe Society of the Americas, and is also a fellow of the Infectious Diseases Society of America and member of numerous medical organizations.

Distinguished Teaching Award

10

RECOGNITIONS

Dr. Ronald Rubin poses next to his newly-unveiled portrait.

Portrait UnveiledColleagues, former students, family, and friends gathered in Erny Auditorium on Oct. 12 for the portrait unveiling of Ronald N. Rubin, MD, Professor of Medicine in the Section of Hematology, for having established an outstanding reputation as a clinician-scholar over his 35 years of service to Temple – where he also earned his Doctor of Medicine and undergraduate degrees.

Dr. Rubin has received honors that include Golden Apple awards, the Lindback Award for Distinguished Teaching, the Temple University Great Teacher Award, and selection as dedicatee of the Temple Medicine Class of 2001 Yearbook – a class which included Dr. Rubin’s son, Adam, a nephrologist.

Pam Shadzik and Paul Csigi proudly display their HR Department of the Year Program awards.

Congratulations to TUHS HR TUHS’s Human Resources team was presented with two awards of distinction from the Delaware Valley HR Department of the Year Program, at an awards banquet held Nov. 15 at the Union League Center City.

TUHS was the only nominee, from a field of companies throughout the Delaware Valley, to garner two Excellence Awards this year – one for Excellence in Benefits, and one for Excellence in Leadership Development.

Accepting the awards on behalf of their HR team members were Paul Csigi, Director of Benefits and Pension Administration, and Pam Shadzik, Director of Leadership and Organizational Development.

RELEASE DATE DECEMBER 2012

SUBMIT STORY IDEASPlease submit story ideas about academic, clinical, research and community-service activities and/or awards and honors to:

Editor

Rebecca Harmon 215-707-8229 Rebecca.Harmon@tuhs.temple.edu

Managing Editor

Christopher Guadagnino, PhD Christopher.Guadagnino@tuhs.temple.edu

Contributing Editors

Gia Ippolito School of Podiatric Medicine Giavanna.ippolito@temple.edu

Brenda Malinics School of Pharmacy brenda.malinics@temple.edu

Christine Mora College of Health Professions & Social Work cmora@temple.edu

Diana Quattrone Fox Chase Cancer Center Diana.Quattrone@fccc.edu

Frank M. Torrisi, DDS, MBA Maurice H. Kornberg School of Dentistry Frank.Torrisi@temple.edu

Giselle Zayon School of Medicine Giselle.Zayon@temple.edu

For additional news, readers are encouraged to view the websites of each School/College or Hospital of Temple University’s Health Sciences Campus.

Temple Health Sciences News Digest earned a Gold Award in the MarCom 2012 International Awards Competition, which recognizes outstanding creative achievement by marketing and communication professionals. The MarCom Awards program is administered by the Association of Marketing and Communication Professionals.

Competing against over 6,000 entries from throughout the United States, Canada and several other countries, the News Digest (September, 2011 issue) was judged worthy of a Gold Award in the “E-Communication/ E-Newsletter” category.

“Temple Health Sciences News Digest was introduced by Dr. Larry Kaiser to theTemple Health community to enhance the communications and collaborative activities between and among all members of Temple’s healthcare enterprise,” said Rebecca Harmon, Assistant Vice President of Communications & Editor of the News Digest. “On behalf of the Communications team, we are pleased that our efforts to meet that goal have been recognized by our peers with this prestigious award.”

Temple Health Sciences News Digest Wins Gold Award in International Competition